Cardiff Park Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.03M Buy
856
+21
+3% +$21.5K 0.08% 112
2026
Q1
$768K Buy
835
+14
+2% +$14.2K 0.06% 141
2025
Q4
$882K Hold
821
0.07% 131
2025
Q3
$626K Hold
821
0.05% 161
2025
Q2
$640K Hold
821
0.06% 146
2025
Q1
$678K Hold
821
0.07% 135
2024
Q4
$634K Hold
821
0.06% 138
2024
Q3
$727K Sell
821
-22
-3% -$19.8K 0.07% 127
2024
Q2
$763K Hold
843
0.07% 119
2024
Q1
$656K Hold
843
0.06% 137
2023
Q4
$491K Hold
843
0.05% 152
2023
Q3
$453K Hold
843
0.06% 151
2023
Q2
$395K Hold
843
0.05% 167
2023
Q1
$290K Hold
843
0.04% 188
2022
Q4
$308K Sell
843
-4
-0.5% -$1.42K 0.04% 192
2022
Q3
$274K Buy
+847
New +$268K 0.04% 197

Other funds holding LLY

Cardiff Park Advisors's LLY Position: Q2 2026 in Review

Cardiff Park Advisors increased its Eli Lilly (LLY) stake by 2.5% in Q2 2026, buying an estimated $21.5K and bringing the position to 856 shares worth $1.03M. The position accounts for 0.08% of the portfolio, ranked #112.

Cardiff Park Advisors first reported a position in LLY in Q3 2022 and has held it in 16 quarters since. 4,637 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Cardiff Park Advisors held 856 shares of Eli Lilly worth $1.03M as of Q2 2026.
  • Cardiff Park Advisors bought 21 Eli Lilly shares in Q2 2026, an estimated $21.5K.
  • Eli Lilly made up 0.08% of Cardiff Park Advisors's portfolio in Q2 2026, its #112 holding.
  • Cardiff Park Advisors first reported a position in Eli Lilly in Q3 2022 and has held it in 16 quarters since.
  • 4,637 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Cardiff Park Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.